Claudio Gasperini


Ontology type: schema:Person     


Person Info

NAME

Claudio

SURNAME

Gasperini

Publications in SciGraph latest 50 shown

  • 2018-12 FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis in SCIENTIFIC REPORTS
  • 2018-12 Induction treatment strategy in multiple sclerosis: a review of past experiences and future perspectives in MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS
  • 2018-12 Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation in SCIENTIFIC REPORTS
  • 2018-12 Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl® in NEUROLOGY AND THERAPY
  • 2018-10 Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study in CNS DRUGS
  • 2018-09 Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report in JOURNAL OF NEUROLOGY
  • 2018-05 A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study in JOURNAL OF NEUROLOGY
  • 2018-03-20 The current role of MRI in differentiating multiple sclerosis from its imaging mimics in NATURE REVIEWS NEUROLOGY
  • 2018-03-09 The current role of MRI in differentiating multiple sclerosis from its imaging mimics in NATURE REVIEWS NEUROLOGY
  • 2017-12 A Comprehensive Review on Copemyl® in NEUROLOGY AND THERAPY
  • 2017-12 Discrepancies between urinary symptoms assessment and objective bladder dysfunctions in multiple sclerosis in MULTIPLE SCLEROSIS AND DEMYELINATING DISORDERS
  • 2017-11 Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis in MOLECULAR NEUROBIOLOGY
  • 2017-05 A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band in JOURNAL OF NEUROLOGY
  • 2017-02 Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis in JOURNAL OF NEUROLOGY
  • 2016-04 Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems in JOURNAL OF NEUROLOGY
  • 2015-06 FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients in CELL DEATH & DISEASE
  • 2015-05 FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients in CELL DEATH & DISEASE
  • 2013-02 A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy in NEUROLOGICAL SCIENCES
  • 2013 Evoluzione della malattia in ASPETTI PSICOLOGICI NELLA SCLEROSI MULTIPLA
  • 2009-12 Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study in BMC NEUROLOGY
  • 2009-10 New oral drugs for multiple sclerosis in NEUROLOGICAL SCIENCES
  • 2006-03 Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis in JOURNAL OF NEUROLOGY
  • 2002-01 Monthly corticosteroids decrease neutralizing antibodies to IFNβ1b: a randomized trial in multiple sclerosis in JOURNAL OF NEUROLOGY
  • 2001-11 Differential diagnosis in multiple sclerosis in NEUROLOGICAL SCIENCES
  • 2000-01 The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement in JOURNAL OF NEUROLOGY
  • 1999-10 Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images in JOURNAL OF NEUROLOGY
  • 1999-08 Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging in JOURNAL OF NEUROLOGY
  • 1999-06 Fatigue and magnetic resonance imaging activity in multiple sclerosis in JOURNAL OF NEUROLOGY
  • 1999-06 Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon β1a in JOURNAL OF NEUROLOGY
  • 1999-03 A comparison of the sensitivity of monthly unenhanced and enhanced MRI techniques in detecting new multiple sclerosis lesions in JOURNAL OF NEUROLOGY
  • 1997-04 Quantitative magnetic resonance analysis in vascular dementia in JOURNAL OF NEUROLOGY
  • 1997-03 Four-year follow-up of a case of acute multiple sclerosis of the Marburg type in NEUROLOGICAL SCIENCES
  • 1997-02 Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome in JOURNAL OF NEUROLOGY
  • 1996-05 High-dose contrast-enhanced MRI in multiple sclerosis in NEURORADIOLOGY
  • 1995 MRI and neuropsychological correlates in presumed vascular dementia in PROCEEDINGS OF THE XV SYMPOSIUM NEURORADIOLOGICUM
  • 1992 Early Treatment of Stroke in Man in NEUROPSYCHOLOGICAL REHABILITATION
  • 1991-06 Irreversible total blindness in multiple sclerosis in NEUROLOGICAL SCIENCES
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.416308.8", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5570.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8142.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5611.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7841.a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Gasperini", 
        "givenName": "Claudio", 
        "id": "sg:person.0654305677.20", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0002-3959-4067"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654305677.20", 
          "https://orcid.org/0000-0002-3959-4067"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:50", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_570.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0654305677.20'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0654305677.20'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0654305677.20'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0654305677.20'


     

    This table displays all metadata directly associated to this object as RDF triples.

    29 TRIPLES      11 PREDICATES      17 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0654305677.20 schema:affiliation Ne66c2e262c4f4b7b87abf0f6097160d1
    2 https://www.grid.ac/institutes/grid.5570.7
    3 https://www.grid.ac/institutes/grid.5611.3
    4 https://www.grid.ac/institutes/grid.7841.a
    5 https://www.grid.ac/institutes/grid.8142.f
    6 schema:familyName Gasperini
    7 schema:givenName Claudio
    8 schema:identifier N626b322efe9b44dcaade48c01bbc9df7
    9 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0654305677.20
    10 https://orcid.org/0000-0002-3959-4067
    11 schema:sdDatePublished 2019-03-07T14:50
    12 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    13 schema:sdPublisher Na2f2db55b36c4910bc4719078fb0b4c4
    14 sgo:license sg:explorer/license/
    15 sgo:sdDataset persons
    16 rdf:type schema:Person
    17 N626b322efe9b44dcaade48c01bbc9df7 schema:name orcid_id
    18 schema:value 0000-0002-3959-4067
    19 rdf:type schema:PropertyValue
    20 Na2f2db55b36c4910bc4719078fb0b4c4 schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 Ne66c2e262c4f4b7b87abf0f6097160d1 schema:affiliation https://www.grid.ac/institutes/grid.416308.8
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 https://www.grid.ac/institutes/grid.416308.8 schema:Organization
    26 https://www.grid.ac/institutes/grid.5570.7 schema:Organization
    27 https://www.grid.ac/institutes/grid.5611.3 schema:Organization
    28 https://www.grid.ac/institutes/grid.7841.a schema:Organization
    29 https://www.grid.ac/institutes/grid.8142.f schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...